Xconomy National

Archives

by in

Entry	Author	Date	Location
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News	Erin Kutz	08/19/11	Boston
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News	Erin Kutz	08/17/11	Boston
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments	Arlene Weintraub	08/15/11	Boston
Pulmatrix Secures $14,000,000 Series B Funding	VentureDeal	08/15/11	Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra	Gregory T. Huang	04/19/11	Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41	Luke Timmerman	02/10/11	Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News	Rebecca Zacks	12/17/10	Boston
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats	Ryan McBride	12/14/10	Boston
Bay State Venture Funding Perked Up in November: There Were Even Some Energy Deals	Robert Buderi	12/11/09	Boston
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News	Rebecca Zacks	11/11/09	Boston
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News	Rebecca Zacks	11/04/09	Boston
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs	Luke Timmerman	11/02/09	Boston
Pulmatrix Receives $30,200,000 Series B Round	VentureDeal	11/02/09	Boston
5AM Ventures Beats Goal for 3rd Fund	Roxanne Palmer	07/07/09	Boston
The Transformative Twelve: Presenting the XSITE Xpo Showcase	Editors	06/19/09	Boston
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News	Rebecca Zacks	06/10/09	Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment	Luke Timmerman	06/09/09	Boston
Investors Wire $10M to Quattro Wireless, NKT Therapeutics Nabs $8M, Still River Makes $33M Worth of Waves, & More Boston-Area Deals News	Rebecca Zacks	03/20/09	Boston
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News	Rebecca Zacks	03/18/09	Boston
Pulmatrix Inhales $3M Financing	Ryan McBride	03/13/09	Boston
First Inhalable TB Vaccine Being Prepped for Clinical Trials By Harvard, MEND Scientists	Luke Timmerman	10/16/08	Boston
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News	Rebecca Zacks	09/24/08	Boston
Pulmatrix, Emerging From Stealth Mode, Makes Aerosols to Kill Flu and Bacterial Bugs in the Lungs	Luke Timmerman	09/18/08	Boston
Page 1 of 1